TRILLIUM THERAPEUTICS INC. 35,731,818 Common Shares 1,250,000 Series II Non- Voting Convertible First Preferred Shares UNDERWRITING AGREEMENTUnderwriting Agreement • January 23rd, 2020 • Trillium Therapeutics Inc. • Pharmaceutical preparations • New York
Contract Type FiledJanuary 23rd, 2020 Company Industry Jurisdiction